Vector Models and Indexing for Lead Optimization in Clinical Trial Pre-screening

Data in the lead optimization phase primarily originates from high-throughput screening (HTS) experimental reports, computer-aided drug design (CADD)

Data Characteristics in This Category

Data in the lead optimization phase primarily originates from high-throughput screening (HTS) experimental reports, computer-aided drug design (CADD) simulation results, in vitro ADMET (absorption, distribution, metabolism, excretion, and toxicity) evaluation data, and early toxicology reports. This data updates frequently, especially during multi-round structural optimization processes. New compound structures, activity data, and physicochemical property data can be generated weekly or even daily. Document structures typically include chemical structures (SMILES, InChIKey), biological activity values (IC50, EC50, Ki, usually in nM or µM), affinity data, solubility (in µg/mL or mg/mL), metabolic stability (e.g., half-life, in minutes or hours), and preliminary toxicity indicators (e.g., cytotoxicity, in µM). Additionally, metadata fields like experimental conditions and data source batches are included.

Constraints Imposed by These Features on "Vector Models and Indexing"

The rapid update frequency of lead optimization data requires vector indexes to support efficient incremental updates or rebuilding. This ensures the model always performs pre-screening based on the latest data. Compound structures, as core information, require specialized encoding methods (such as molecular fingerprints or graph neural network embeddings) for effective vectorization. This differs significantly from vector models processing natural language text. Numerical fields like biological activity values and physicochemical properties need to be integrated with structural information during vectorization, or processed via multimodal embedding techniques, to capture multi-dimensional compound features. Documents contain numerous specialized terms and abbreviations, requiring vector models to possess strong domain knowledge understanding. Furthermore, inconsistent units in the data necessitate standardization during preprocessing to prevent vector distance calculation deviations due to unit differences.

Configuration Settings

Configuration ItemSuggested ValueRationale for this Value
chunk_size150–250 charactersCompound descriptions and experimental results are typically concise. Overly long chunks dilute key information, while overly short chunks may lose context.
chunk_overlap20 charactersEnsures contextual continuity, especially when describing structure-activity relationships, preventing information loss due to splitting.
recall_count10–20 itemsIncreases the recall rate for initial screening, covering more potentially effective compounds or related experimental data.
similarity_thresholdCalibrate by actual measurementRequires experimental adjustment based on the specific dataset and model performance to balance recall and precision.
rerank_count5 itemsSelects the most relevant compounds or data snippets from the recalled results, providing more focused suggestions.
vector_modeltext-embedding-ada-002 or m3eNeeds to support joint embedding of complex biomolecular structure information and text descriptions, and exhibit good domain adaptability.

Three Common Mistakes

  • FastGPT calls to the vector model return a 401 Unauthorized error code. This usually indicates an incorrect or expired API Key configuration. Check OPENAI_API_KEY or other model service keys.
  • The knowledge base merging component processes documents containing compound structures or experimental reports, unexpectedly removing duplicate content. This leads to index order errors or critical data loss. This typically occurs when default deduplication strategies treat structures or similar descriptions as duplicates. Custom splitting rules and disabled automatic deduplication are required.
  • Search results recall compounds with insufficient structural or activity relevance to the query compound. This manifests as a sufficient number of recalled items but low relevance. This may be due to the vector model's insufficient understanding of specialized terms and molecular structural features in the biomedical domain, or vectorization methods failing to fully capture the deep connections between structure and function.

How to Confirm Correct Configuration

  • Using the FastGPT interface, query for known active compounds. Check if the recalled results include structurally similar or activity-related compounds, and verify if their ranking is reasonable.
  • Examine the vector index build logs to confirm no interruptions or skips occurred due to data format errors, encoding issues, or API call failures.
  • Select a batch of data pairs with clear structure-activity relationships. Perform similarity search tests to evaluate the performance of similarity_threshold under different queries, determining if it effectively distinguishes highly relevant from less relevant results.
  • Regularly test incremental updates with a small amount of new data. Verify the update process runs smoothly and check if the updated index maintains stable query performance and recall effectiveness.

Note: The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.